Characterization, stabilization and activity of uricase loaded in lipid vesicles

International Journal of Pharmaceutics

Volumn 384, Issue 1-2, 2010, Pages 165-172

  Tan, Q Y ^a   Wang, N ^b   Yang, H ^c   Zhang, L K ^b   Liu, S ^b   Chen, L ^a   Liu, J ^b   Zhang, L ^b   Hu, N N ^b   Zhao, C J ^b   Zhang, J Q ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Characterization; Enzymatic activity; Lipid vesicles; Stability; Uricase

Indexed keywords

BORIC ACID; CHOLESTEROL; FLUORESCEIN ISOTHIOCYANATE; PHOSPHATIDYLCHOLINE; URATE OXIDASE;

ALKALINITY; AQUEOUS SOLUTION; ARTICLE; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISSOCIATION; DRUG ACTIVITY; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; ENZYME ACTIVITY; EVAPORATION; HYDROPHOBICITY; IN VITRO STUDY; LIPID VESICLE; PARTICLE SIZE; PH; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; STORAGE TEMPERATURE; THERMOSTABILITY; ZETA POTENTIAL;

ANIMALS; CATTLE; DRUG CARRIERS; DRUG STABILITY; ENZYME ACTIVATION; LIPIDS; URATE OXIDASE;

EID: 70649103021     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.09.036     Document Type: Article

References (34)

1. Attwood P.V., and Geeves M.A. Changes in catalytic activity and association state of pyruvate carboxylase which are dependent on enzyme concentration. Arch. Biochem. Biophys. 401 (2002) 63-72
2. Bomalaski J.S., Holtsberg F.W., Ensor C.M., and Clark M.A. Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies. J. Rheumatol. 29 (2002) 1942-1949
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
4. Chuang C.K., Wang T.J., Yeung C.Y., Hsieh W.S., Lin D.S., Ho S.C., and Lin S.P. Interference and blood sample preparation for a pyruvate enzymatic assay. Clin. Biochem. 39 (2006) 74-77
5. Domènech O., Redondo L., Montero M.T., and Hernandez-Borrell J. Specific adsorption of Cytochrome c on cardiolipin-glycerophospholipid monolayers and bilayers. Langmuir 23 (2007) 5651-5656
6. Georgiou C.D., Grintzalis K., Zervoudakis G., and Papapostolou I. Mechanism of Coomassie brilliant blue G-250 binding to proteins: a hydrophobic assay for nanogram quantities of proteins. Anal. Bioanal. Chem. 391 (2008) 391-403
7. Hashemnia S., Moosavi-Movahedi A.A., Ghourchian H., Ahmad F., Hakimelahi G.H., and Saboury A.A. Diminishing of aggregation for bovine liver catalase through acidic residures modification. Int. J. Biol. Macromol. 40 (2006) 47-53
8. Ihler G., Lantzy A., Purpura J., and Glew R.H. Enzymatic degradation of uric acid by uricase-loaded human erythrocytes. J. Clin. Invest. 56 (1975) 595-602
9. Koppel D.E. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. J. Chem. Phys. 57 (1972) 4814-4816
10. Kuboi R., Yoshimoto M., Walde P., and Luisi P.L. Refolding of carbonic anhydrase assisted by 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine liposomes. Biotechnol. Prog. 13 (1997) 828-836
11. Lu B., Zhang J., and Yang H. Nonphospholipid vesicles of carboplatin for lung targeting. Drug Deliv. 10 (2003) 87-94
12. Magnani M., Mancini U., Bianchi M., and Fazi A. Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation. Adv. Exp. Med. Biol. 326 (1992) 189-194
13. Mei G., Di Venere A., Buganza M., Vecchini P., Rosato N., and Finazzi-Agro' A. Role of quaternary structure in the stability of dimeric proteins: the case of ascorbate oxidase. Biochemistry 36 (1997) 10917-10922
14. Nishida Y., Kamatani N., and Miyamoto T. Hypouricaemic effect after oral administration in chichens of poly-ethylene glycol-modified uricase entrapped in liposomes. J. Pharm. Pharmacol. 36 (1984) 354-355
15. Nishimura H., Yoshida K., and Yokota Y. Physicochemical properties and states of sulfhydryl groups of uricase from Candida utilis. J. Biochem. 91 (1982) 41-48
16. Oloughlin J., Bruder J., and Lysaght M.J. Degradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymes. ASAIO J. 50 (2004) 253-260
17. Paust G., Sergi M., and Veronese F.M. Anti-cancer PEG-enzymes: 30 years old, but still a current approach. Adv. Drug Deliv. Rev. 60 (2008) 69-78
18. Poznansky M.J. In vitro and in vivo activity of soluble cross-linked uricase-albumin polymers: a model for enzyme therapy. Life Sci. 24 (1979) 153-158
19. Poltorak O.M., Chukhray E.S., and Torshin I.Y. Dissociative thermal inactivation, stability, and activity of oligomeric enzymes. Biochemistry 63 (1998) 303-311
20. Prajapati S., Bhakuni V., Babu K.R., and Jain S.K. Alkaline unfolding and salt-induced folding of bovine liver catalase at high pH. Eur. J. Biochem. 255 (1998) 178-184
21. Reddy G.B., Bharadwaj S., and Surolia A. Thermal stability and mode of oligomerization of the tetrameric peanut agglutinin: a differential scanning calorimetry study. Biochemistry 38 (1999) 4464-4470
22. Roberts S.A., Kellaway I.W., Taylor K.M., Warburton B., and Peters K. Combined surface pressure-interfacial shear rheology studies of the interaction of proteins with spread phospholipid monolayers at the air-water interface. Int. J. Pharm. 300 (2005) 48-55
23. Sherman M.R., Saifer M.G.P., and Perezruiz F. PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Adv. Drug Deliv. Rev. 60 (2008) 59-68
24. Sherman, M.R., Saifer, M.G.P., Williams, L.D., et al., 2004. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates. US Patent 6783965 B1. Mountain View Pharmaceuticals, Inc./Duke University.
25. Stove V., Wuyts B., and Delanghe J. Perchloric acid treatment to stabilize uric acid concentrations in blood samples of patients receiving uric acid oxidase (rasburicase) therapy. Clin. Chem. 15 2 (2007) 369-370
26. Walde P., and Ichikawa S. Enzymes inside lipid vesicles: preparation, reactivity and applications. Biomol. Eng. 18 (2001) 143-177
27. Yasuda Y., Fujita T., Takakura Y., Hashida M., and Sezaki H. Biochemical and Biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycol. Chem. Pharm. Bull. 38 (1990) 2053-2056
28. Yoshimoto M., Satkmoto H., Yoshimoto N., Kuboi R., and Nakao K. Stabilization of quaternary structure and activity of bovine liver catalase through encapsulation in liposomes. Enzyme Microb. Technol. 41 (2007) 849-858
29. Yoshimoto M., Miyazaki Y., Kudo Y., Fukunaga K., and Nakao K. Glucose oxidation catalyzed by liposomal glucose oxidase in the presence of catalase-containing liposomes. Biotechnol. Prog. 22 (2006) 704-709
30. Yoshimoto M., Wang S., Fukunaga K., Treyer M., Walde P., and Kuboi R. Enhancement of apparent substrate selectivity of proteinase K encapsulated in liposomes through a cholate-induced alteration of the bilayer permeability. Biotechnol. Bioeng. 85 (2004) 222-233
31. Yoshimoto M., Wang S., Fukunaga K., Fournier D., Walde P., and Kuboi R. Novel immobilized liposomal glucose oxidase system using the channel protein ompf and catalase. Biotechnol. Bioeng. 90 (2005) 231-238
32. Zhang J.Q., Liu J., Li X.L., and Jasti B.R. Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug Deliv. 14 (2007) 381-387
33. Zhang J.Q., Zhang Z.R., Yang H., Tan Q.Y., Qin S.R., and Qiu X.L. Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies. Pharm. Res. 22 (2005) 573-583
34. Zhao, Y.S., Zhao, L., Yang, G.Q., Tao, J., Bu, Y.Q., Liao, F., 2006. Characterization of n uricase from bacillus fastidious A.T.C.C. 26904 and its application to serum uric acid assay by a patented kinetic uricase method. Biotechnol. Appl. Biochem. 45, 75-80.